All In Biotech

Drug Trial Radar · NCT06489028

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Therapy-resistant CVU (Phase III)

A Pivotal, Randomized, Placebo-controlled, Double-blind, Multicenter, International Phase III Clinical Trial to Investigate the Efficacy and Safety of Allo-APZ2-CVU on Wound Healing of Therapy-Resistant Non-Healing Chronic Venous Ulcers (CVU)

Last checked: Nov 20, 2026Latest source record: Oct 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Title says "pivotal". Randomized with 250 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Dec 26, 2024

Primary completion

Apr 2027

Study completion Sep 2027

Sponsor

Lead sponsor
RHEACELL GmbH & Co. KGIndustry
Sponsor type
Industry
Collaborators
FGK Clinical Research GmbH
First posted
Jul 5, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of this clinical trial is to investigate the efficacy and safety of allo-APZ2-CVU, administered topically on therapy-resistant non-healing CVUs compared to placebo.

Conditions

  • Venous Leg Ulcer

Interventions

  • allo-APZ2-CVUDrug

    Allogeneic dermal ABCB5-positive Mesenchymal Stromal Cells (ABCB5+ MSCs)

  • PlaceboDrug

    Placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Complete wound closureTime frame: 18 weeks

Locations

15 sites in 12 countries. Site status is shown where the registry gives one.

  • RHEACELL Clinical Trial Site

    Hialeah, Florida

  • RHEACELL Clinical Trial Site

    Miami, Florida

  • RHEACELL Clinical Trial Site

    Boston, Massachusetts

  • RHEACELL Clinical Trial Site

    Minneapolis, Minnesota

  • RHEACELL Clinical Trial Site

    Multiple Locations, Austria

  • RHEACELL Clinical Trial Site

    Multiple Locations, Czechia

  • RHEACELL Clinical Trial Site

    Multiple Locations, France

  • RHEACELL Clinical Trial Site

    Several Locations, Germany

  • RHEACELL Clinical Trial Site

    Multiple Locations, Hungary

  • RHEACELL Clinical Trial Site

    Multiple Locations, Italy

  • RHEACELL Clinical Trial Site

    Multiple Locations, Netherlands

  • RHEACELL Clinical Trial Site

    Multiple Locations, Poland

  • RHEACELL Clinical Trial Site

    Multiple Locations, Slovakia

  • RHEACELL Clinical Trial Site

    Multiple Locations, Sweden

  • RHEACELL Clinical Trial Site

    Multiple Locations, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.